Optimizing Aging Male Symptom Questionnaire Through Genetic Algorithms Based Machine Learning Techniques
- PMID: 32009307
- PMCID: PMC7752504
- DOI: 10.5534/wjmh.190077
Optimizing Aging Male Symptom Questionnaire Through Genetic Algorithms Based Machine Learning Techniques
Abstract
Purpose: Genetic algorithm (GA) is a machine learning optimization strategy where sample strategies compete for fitness to evolve an optimum solution. This study evolves the Aging Male Symptoms (AMS) with GA to better identify late onset hypogonadism (LOH) with serum testosterone.
Materials and methods: GA was trained on a training set of standard AMS questionnaire on a nationwide LOH epidemiology study. Random matrices of selectors for particular items were generated. Each generation of was evolved through a fitness function determined by sensitivity. Threshold to determine positive serum testosterone level for LOH was randomized for each competing strategy. After 2,000 runs, with each run producing the best result out of a set of 3,000 randomly generated sets evolved through 300 generations, the best AMS selection matrix was then applied to a separately enrolled validation set to compare outcomes.
Results: Predictability for serum testosterone levels dropped markedly above 3.5 ng/mL during pilot training. Limiting the training to testosterone thresholds between 2.5 and 3.5 ng/mL the GA 93 different strategies. Only a selection of 5 items, determining for a threshold of 20 points and determining for a serum testosterone level of 3.16 ng/mL, showed robust reproducibility within the internal validation set. Applying these conditions to the independent validation set showed sensitivity improved from 0.66 to 0.77, with a specificity of 0.07 to 0.19, respectively.
Conclusions: GA method of selecting questionnaires improved AMS questionnaire significantly. This method can be easily applied to other questionnaires that do not correlate with physiological markers.
Keywords: Hypogonadism; Machine learning; Questionnaire design; Testosterone.
Copyright © 2021 Korean Society for Sexual Medicine and Andrology.
Conflict of interest statement
The authors have nothing to disclose.
Figures




Similar articles
-
Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men.Springerplus. 2016 Jun 16;5(1):729. doi: 10.1186/s40064-016-2531-8. eCollection 2016. Springerplus. 2016. PMID: 27375998 Free PMC article.
-
Androgen Receptor CAG Repeat Length as a Risk Factor of Late-Onset Hypogonadism in a Korean Male Population.Sex Med. 2018 Sep;6(3):203-209. doi: 10.1016/j.esxm.2018.04.002. Epub 2018 Apr 26. Sex Med. 2018. PMID: 29706560 Free PMC article.
-
Comparison of questionnaires used for screening and symptom identification in hypogonadal men.Aging Male. 2014 Dec;17(4):195-8. doi: 10.3109/13685538.2014.963041. Epub 2014 Sep 23. Aging Male. 2014. PMID: 25247629 Review.
-
Profile of serum testosterone levels after application of testosterone ointment (glowmin) and its clinical efficacy in late-onset hypogonadism patients.J Sex Med. 2008 Jul;5(7):1727-36. doi: 10.1111/j.1743-6109.2007.00689.x. J Sex Med. 2008. PMID: 18093097
-
[Update of researches on and utilization of screening questionnaires on late-onset hypogonadism in males].Zhonghua Nan Ke Xue. 2008 Jun;14(6):555-9. Zhonghua Nan Ke Xue. 2008. PMID: 18649759 Review. Chinese.
Cited by
-
Korean Ginseng Berry Extract Enhances the Male Steroidogenesis Enzymes In Vitro and In Vivo.World J Mens Health. 2023 Apr;41(2):446-459. doi: 10.5534/wjmh.220075. Epub 2023 Jan 2. World J Mens Health. 2023. PMID: 36649918 Free PMC article.
-
Utilization of artificial intelligence in Men's Health: Opportunities for innovation and quality improvement.Int J Impot Res. 2025 Jun 27. doi: 10.1038/s41443-025-01112-8. Online ahead of print. Int J Impot Res. 2025. PMID: 40579440 Review.
-
Artificial Intelligence for Clinical Management of Male Infertility, a Scoping Review.Curr Urol Rep. 2024 Nov 9;26(1):17. doi: 10.1007/s11934-024-01239-z. Curr Urol Rep. 2024. PMID: 39520645 Free PMC article.
References
-
- Dobs AS. The role of accurate testosterone testing in the treatment and management of male hypogonadism. Steroids. 2008;73:1305–1310. - PubMed
-
- Taniguchi H, Kawa G, Kinoshita H, Matsuda T. Change of aging males' symptoms (AMS) rating scale in Japanese late-onset hypogonadism (LOH) patients administered androgen replacement therapy. J Men Health. 2011;8:S67–S70.
-
- Lunenfeld B, Saad F, Hoesl CE. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male. 2005;8:59–74. - PubMed
-
- Kong XB, Guan HT, Li HG, Zhou Y, Xiong CL. The ageing males' symptoms scale for Chinese men: reliability,validation and applicability of the Chinese version. Andrology. 2014;2:856–861. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources